Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia

被引：0
|
作者：
Molica, Stefano [1 ]
Allsup, David [1 ,2 ]
Giannarelli, Diana [3 ]
机构：
[1] Hull Univ Teaching Hosp NHS Trust, Dept Hematol, Kingston Upon Hull, England
[2] Hull York Med Sch, Ctr Biomed, Kingston Upon Hull, England
[3] Sci Directorate Fdn Policlin Univ Agostino Gemelli, Biostat Unit, Rome, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 10期
关键词：
TYROSINE KINASE INHIBITORS; VENETOCLAX;
D O I：
10.1002/ajh.27437
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2041 / 2044
页数：4
相关论文
共 50 条
  • [1] Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
    Lachaine, Jean
    Guinan, Kimberly
    Aw, Andrew
    Banerji, Versha
    Fleury, Isabelle
    Owen, Carolyn
    CURRENT ONCOLOGY, 2023, 30 (05) : 4483 - 4498
  • [2] Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    Seymour, John F.
    Jurczak, Wojciech
    Aw, Andrew
    Wach, Malgorzata
    Illes, Arpad
    Tedeschi, Alessandra
    Owen, Carolyn
    Skarbnik, Alan
    Lysak, Daniel
    Eom, Ki-Seong
    Simkovic, Martin
    Pavlovsky, Miguel Arturo
    Kater, Arnon Philip
    Eichhorst, Barbara
    Miller, Kara
    Munugalavadla, Veerendra
    Yu, Ting
    de Borja, Marianne
    Ghia, Paolo
    AMPLIFY investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 748 - 762
  • [3] A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia
    Cheng, Mindy M.
    Goulart, Bernardo
    Veenstra, David L.
    Blough, David K.
    Devine, Emily Beth
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1004 - 1011
  • [4] Upfront fixed-duration treatment strategies for chronic lymphocytic leukemia in Arab populations: a position statement from the Gulf region
    Yassin, Mohamed A.
    Al Farsi, Khalil
    Hamad, Anas
    Ghasoub, Rola
    Alhuraiji, Ahmad
    Mheidly, Kayane
    Yaseen, Hasan Aal
    Osman, Hani
    Trepel, Martin
    FRONTIERS IN MEDICINE, 2025, 12
  • [5] Network meta-analysis of novel targeted therapies for relapsed/refractory chronic lymphocytic leukemia
    Monica, Magdalena
    Reczek, Monika
    Kawalec, Pawel
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [6] Fixed-Duration First-Line Treatment With Ibrutinib Plus Venetoclax for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Primary Analysis of the Fixed-Duration Cohort of the Phase 2 CAPTIVATE Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (07) : 4 - 5
  • [7] Forest Plot to Compare Therapies in a Network Meta-Analysis in First Line Chronic Lymphocytic Leukemia
    Piciocchi, Alfonso
    Bontempi, Katia
    Fazi, Paola
    Vignetti, Marco
    Mandelli, Franco
    BLOOD, 2012, 120 (21)
  • [8] A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia
    Lee, Cho-Hao
    Chen, Po-Huang
    Lin, Chin
    Wang, Chieh-Yung
    Ho, Ching-Liang
    PLOS ONE, 2020, 15 (01):
  • [9] Comparative safety of novel targeted therapies in relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis
    Monica, Magdalena
    Reczek, Monika
    Kawalec, Pawel
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [10] BUDGET IMPACT ANALYSIS OF FIXED-DURATION IBRUTINIB plus VENETOCLAX AS FRONTLINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Lima, P.
    Matsumoto, V
    Righetto, P.
    VALUE IN HEALTH, 2024, 27 (12)
12345